TrinityPoint Wealth’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,000
Closed -$1.22K 298
2022
Q4
$1.22K Hold
11,000
﹤0.01% 279
2022
Q3
$12K Hold
11,000
﹤0.01% 278
2022
Q2
$20K Hold
11,000
﹤0.01% 276
2022
Q1
$39K Hold
11,000
0.01% 307
2021
Q4
$95K Sell
11,000
-3,250
-23% -$20.7K 0.02% 302
2021
Q3
$108K Buy
14,250
+2,250
+19% +$19K 0.02% 301
2021
Q2
$80K Buy
+12,000
New +$75.6K 0.02% 262

Other funds holding LHDX

TrinityPoint Wealth's LHDX Position: Q1 2023 in Review

TrinityPoint Wealth sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 11,000 shares — an estimated $1.22K sold.

TrinityPoint Wealth first reported a position in LHDX in Q2 2021 and held it in 7 quarters. The position peaked at $108K in Q3 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • TrinityPoint Wealth reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TrinityPoint Wealth sold 11,000 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $1.22K.
  • TrinityPoint Wealth first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • TrinityPoint Wealth's Lucira Health, Inc. Common Stock position peaked at $108K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on TrinityPoint Wealth's 13F filing for Q1 2023, filed 4 May 2023.